• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Long-Term Success: Educating and Supporting Patients on ALK Inhibitors

Opinion
Video

Panelists discuss how proactive patient education, lipid-lowering interventions, and monitoring tools can help patients stay on ALK inhibitor therapy to realize long-term benefits.

ALK Inhibitor Therapy Management

Main Discussion Topics

  • Patient education strategies for lorlatinib therapy adherence
  • Lipid-lowering interventions to support long-term lorlatinib treatment
  • Monitoring tools for patients on ALK inhibitors
  • Patient education methodologies specific to ALK inhibitor therapy

Discussion Questions Posed

  • Grizzard inquired about proactive patient education and lipid-lowering interventions to help patients maintain lorlatinib therapy for long-term benefits

Castronovo asked about potentially useful tools for educating and monitoring patients on ALK inhibitors

Related Videos
4 experts are featured in this series.
4 experts are featured in this series.
5 experts in this video
1 expert in this video
Dr Gerard Criner
Dr Margrit Wiesendanger
4 experts are featured in this series.
4 experts are featured in this series.
Related Content
© 2025 MJH Life Sciences
AJMC®
All rights reserved.